99 related articles for article (PubMed ID: 1593654)
1. Case-control study of factors associated with human T-cell leukemia virus type I infection in southern Miyazaki, Japan.
Stuver SO; Tachibana N; Mueller N
J Natl Cancer Inst; 1992 Jun; 84(11):867-72. PubMed ID: 1593654
[TBL] [Abstract][Full Text] [Related]
2. Determinants of HTLV-1 seroprevalence in Miyazaki Prefecture, Japan: a cross-sectional study.
Stuver SO; Tachibana N; Okayama A; Romano F; Yokota T; Mueller N
J Acquir Immune Defic Syndr (1988); 1992; 5(1):12-8. PubMed ID: 1738083
[TBL] [Abstract][Full Text] [Related]
3. [An epidemiologic study of anti-HTLV-I (antibody to human T cell lymphotropic virus type I) by category of disease in the Kushima district of Miyazaki prefecture].
Hirata M; Kajiyama W; Nakashima K; Noguchi A; Hayashi J; Kashiwagi S; Tanimura N; Shingu T
Kansenshogaku Zasshi; 1991 Feb; 65(2):162-7. PubMed ID: 2066597
[TBL] [Abstract][Full Text] [Related]
4. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
Birmann BM; Breen EC; Stuver S; Cranston B; MartÃnez-Maza O; Falk KI; Okayama A; Hanchard B; Mueller N; Hisada M
Int J Cancer; 2009 Feb; 124(3):614-21. PubMed ID: 18989900
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).
Dumas M; Houinato D; Verdier M; Zohoun T; Josse R; Bonis J; Zohoun I; Massougbodji A; Denis F
AIDS Res Hum Retroviruses; 1991 May; 7(5):447-51. PubMed ID: 1873079
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
Karimi G; Zadsar M; Pourfathollah AA
Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
[TBL] [Abstract][Full Text] [Related]
7. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
Satake M; Yamaguchi K; Tadokoro K
J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.
Umeki K; Umekita K; Hashikura Y; Yamamoto I; Kubo K; Nagatomo Y; Okayama A
Clin Lab; 2017 Feb; 63(2):227-233. PubMed ID: 28182361
[TBL] [Abstract][Full Text] [Related]
9. Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii.
Ho GY; Nomura AM; Nelson K; Lee H; Polk BF; Blattner WA
Am J Epidemiol; 1991 Nov; 134(9):981-7. PubMed ID: 1951296
[TBL] [Abstract][Full Text] [Related]
10. [A survey of HTLV-1 carrier clinics in Japan].
Ishitsuka K; Yamano Y; Utsunomiya A; Uchimaru K
Rinsho Ketsueki; 2015 Jun; 56(6):666-72. PubMed ID: 26256877
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer.
Hirata T; Nakamoto M; Nakamura M; Kinjo N; Hokama A; Kinjo F; Fujita J
J Gastroenterol Hepatol; 2007 Dec; 22(12):2238-41. PubMed ID: 18031387
[TBL] [Abstract][Full Text] [Related]
12. HTLV-I seroprevalence in patients with undefined uveitis in central Japan.
Goto K; Saeki K; Kurita M; Iijima Y; Miyake A; Ohno S
Jpn J Ophthalmol; 1994; 38(2):175-7. PubMed ID: 7967209
[TBL] [Abstract][Full Text] [Related]
13. [Seroepidemiological analysis of the age specific prevalence of anti HTLV-I in Miyazaki Prefecture].
Tachibana N; Okayama A; Murai K; Shioiri S; Shishime E; Ishizaki J; Tsuda K
Kansenshogaku Zasshi; 1990 May; 64(5):570-4. PubMed ID: 2212751
[TBL] [Abstract][Full Text] [Related]
14. Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults.
Birmann BM; Mueller N; Okayama A; Hsieh CC; Tachibana N; Tsubouchi H; Lennette ET; Harn D; Stuver S
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1385-91. PubMed ID: 15298962
[TBL] [Abstract][Full Text] [Related]
15. Endemic impact of human T cell leukemia virus type 1 screening in bone allografts.
Ishidou Y; Matsuyama K; Matsuura E; Setoguchi T; Nagano S; Kakoi H; Hirotsu M; Kawamura I; Yamamoto T; Komiya S
Cell Tissue Bank; 2016 Dec; 17(4):555-560. PubMed ID: 27677902
[TBL] [Abstract][Full Text] [Related]
16. [Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers--1. A seroepidemiological study].
Shirao M; Yoshimura K; Mochizuki M; Araki S; Miyata N; Yamaguchi K; Takatsuki K; Watanabe T; Mori S; Tajima K
Nippon Ganka Gakkai Zasshi; 1993 Jun; 97(6):726-32. PubMed ID: 8328341
[TBL] [Abstract][Full Text] [Related]
17. Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.
Caron M; Besson G; Padilla C; Makuwa M; Nkoghe D; Leroy E; Kazanji M
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006833. PubMed ID: 30359373
[TBL] [Abstract][Full Text] [Related]
18. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan.
Koga Y; Iwanaga M; Soda M; Inokuchi N; Sasaki D; Hasegawa H; Yanagihara K; Yamaguchi K; Kamihira S; Yamada Y
J Med Virol; 2010 Apr; 82(4):668-74. PubMed ID: 20166187
[TBL] [Abstract][Full Text] [Related]
19. [Seroprevalence of HTLV-I in various ocular diseases in central Japan].
Goto K; Kurita M; Watanabe N; Ogi A; Iijima Y; Hanajiri M; Saeki K; Ohno S
Nippon Ganka Gakkai Zasshi; 1995 Aug; 99(8):959-63. PubMed ID: 7676898
[TBL] [Abstract][Full Text] [Related]
20. Findings from the Miyazaki Cohort Study.
Mueller N; Okayama A; Stuver S; Tachibana N
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S2-7. PubMed ID: 8797696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
